LRP6 and coronary artery disorder: As explained, genetic investigations of families or populations with extreme forms of MetS and/or early onset CAD have led to the discovery of both rare and common mutations in LRP6. These mutations were associated with the risk of elevated LDL-cholesterol (LDL-C) [48].